<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Otrompke, John</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Resiere, Dabor</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">When to Consider Leptospirosis in Unexplained Myocarditis</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-12</style></pages><abstract><style  face="normal" font="default" size="100%">Although the primary treatment for typical leptospirosis is antimicrobial therapy in the form of penicillin and doxycycline, assessment of left ventricular (LV) systolic function should also be performed in patients with this condition. Findings of new LV dysfunction (ejection fraction &lt;50%) may provide evidence of associated myocarditis, which is an important finding.</style></abstract><number><style face="normal" font="default" size="100%">14</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>